Related references
Note: Only part of the references are listed.Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions
Shaoyong Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia
F. Peng et al.
ONCOGENE (2018)
Discovery of hidden allosteric sites as novel targets for allosteric drug design
Shaoyong Lu et al.
DRUG DISCOVERY TODAY (2018)
MiR-155-5p inhibits PDK1 and promotes autophagy via the mTOR pathway in cervical cancer
Fang Wang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Computational Insights into the Interactions between Calmodulin and the c/nSH2 Domains of p85 Regulatory Subunit of PI3K: Implication for PI3K Activation by Calmodulin
Duan Ni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
AlloFinder: a strategy for allosteric modulator discovery and allosterome analyses
Min Huang et al.
NUCLEIC ACIDS RESEARCH (2018)
PDK1: At the crossroad of cancer signaling pathways
Paolo Armando Gagliardi et al.
SEMINARS IN CANCER BIOLOGY (2018)
Molecular Dynamics Simulations and Dynamic Network Analysis Reveal the Allosteric Unbinding of Monobody to H-Ras Triggered by R135K Mutation
Duan Ni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1
Andrew A. Wylie et al.
NATURE (2017)
Serine/Threonine Kinase 3-Phosphoinositide-Dependent Protein Kinase-1 (PDK1) as a Key Regulator of Cell Migration and Cancer Dissemination
Laura Di Blasio et al.
CANCERS (2017)
Fragment-based design, synthesis, biological evaluation, and SAR of 1H-benzo[d]imidazol-2-yl)-1H-indazol derivatives as potent PDK1 inhibitors
Ting Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Designed covalent allosteric modulators: an emerging paradigm in drug discovery
Shaoyong Lu et al.
DRUG DISCOVERY TODAY (2017)
Discovery of novel 7-azaindoles as PDK1 inhibitors
Margarita Wucherer-Plietker et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Ras Conformational Ensembles, Allostery, and Signaling
Shaoyong Lu et al.
CHEMICAL REVIEWS (2016)
Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view
Shaoyong Lu et al.
CHEMICAL SOCIETY REVIEWS (2016)
Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
Valentina Cappello et al.
SCIENTIFIC REPORTS (2016)
Bidirectional Allosteric Communication between the ATP-Binding Site and the Regulatory PIF Pocket in PDK1 Protein Kinase
Joerg O. Schulze et al.
CELL CHEMICAL BIOLOGY (2016)
PDK1: A signaling hub for cell migration and tumor invasion
Paolo Armando Gagliardi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2015)
Drugs for Allosteric Sites on Receptors
Cody J. Wenthur et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54 (2014)
Synthesis and biological evaluation of substituted 3-anilino-quinolin-2(1H)-ones as PDK1 inhibitors
Nathan J. O'Brien et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Recent computational advances in the identification of allosteric sites in proteins
Shaoyong Lu et al.
DRUG DISCOVERY TODAY (2014)
Harnessing Allostery: A Novel Approach to Drug Discovery
Shaoyong Lu et al.
MEDICINAL RESEARCH REVIEWS (2014)
A small-molecule mimic of a peptide docking motif inhibits the protein kinase PDK1
T. Justin Rettenmaier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Strategies for the Selective Regulation of Kinases with Allosteric Modulators: Exploiting Exclusive Structural Features
Zhizhou Fang et al.
ACS CHEMICAL BIOLOGY (2013)
AGC protein kinases: From structural mechanism of regulation to allosteric drug development for the treatment of human diseases
Jose M. Arencibia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2013)
Allostery in Disease and in Drug Discovery
Ruth Nussinov et al.
CELL (2013)
Selective 3-Phosphoinositide-Dependent Kinase 1 (PDK1) Inhibitors: Dissecting the Function and Pharmacology of PDK1
Jesus R. Medina
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Characterization of fragmented 3-phosphoinsitide-dependent protein kinase-1 (PDK1) by phosphosite-specific antibodies
Jisoo Park et al.
LIFE SCIENCES (2013)
The activation loop of PKA catalytic isoforms is differentially phosphorylated by Pkh protein kinases in Saccharomyces cerevisiae
Steven Haesendonckx et al.
BIOCHEMICAL JOURNAL (2012)
Thieno[3,2-d]pyrimidin-4(3H)-one derivatives as PDK1 inhibitors discovered by fragment-based screening
Angeline C. -H. Lee et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Substrate-Selective Inhibition of Protein Kinase PDK1 by Small Compounds that Bind to the PIF-Pocket Allosteric Docking Site
Katrien Busschots et al.
CHEMISTRY & BIOLOGY (2012)
Regulation of Protein Kinase C-related Protein Kinase 2 (PRK2) by an Intermolecular PRK2-PRK2 Interaction Mediated by Its N-terminal Domain
Angelika F. Bauer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
2-(3-Oxo-1,3-diphenylpropyl)malonic Acids as Potent Allosteric Ligands of the PIF Pocket of Phosphoinositide-Dependent Kinase-1: Development and Prodrug Concept
Adriana Wilhehm et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Enabling Large-Scale Design, Synthesis and Validation of Small Molecule Protein-Protein Antagonists
David Koes et al.
PLOS ONE (2012)
Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery
Daniel A. Erlanson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Allosteric Regulation of Protein Kinase PKCζ by the N-Terminal C1 Domain and Small Compounds to the PIF-Pocket
Laura A. Lopez-Garcia et al.
CHEMISTRY & BIOLOGY (2011)
Genetic and Pharmacological Inhibition of PDK1 in Cancer Cells CHARACTERIZATION OF A SELECTIVE ALLOSTERIC KINASE INHIBITOR
Kumiko Nagashima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
4-Benzimidazolyl-3-Phenylbutanoic Acids As Novel Pif-Pocket-Targeting Allosteric Inhibitors of Protein Kinase PKCζ
Wolfgang Froehner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Allosteric Modulation of Family C G-Protein-Coupled Receptors: from Molecular Insights to Therapeutic Perspectives
Stephan Urwyler
PHARMACOLOGICAL REVIEWS (2011)
Turning a protein kinase on or off from a single allosteric site via disulfide trapping
Jack D. Sadowsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Design and synthesis of benzoazepin-2-one analogs as allosteric binders targeting the PIF pocket of PDK1
Linyi Wei et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Structure-based optimization of potent PDK1 inhibitors
Mauro Angiolini et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Non-ATP Competitive Protein Kinase Inhibitors
L. Garuti et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Discovery of PDK1 Kinase Inhibitors with a Novel Mechanism of Action by Ultrahigh Throughput Screening
Ekaterina V. Bobkova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The nuts and bolts of AGC protein kinases
Laura R. Pearce et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Non-ATP competitive protein kinase inhibitors as anti-tumor therapeutics
Lindsay O. Kirkland et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Benzo[c][2,7]naphthyridines as inhibitors of PDK-1
Kyung-Hee Kim et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
3-Phosphoinositide-Dependent Kinase 1 Potentiates Upstream Lesions on the Phosphatidylinositol 3-Kinase Pathway in Breast Carcinoma
Matthew Maurer et al.
CANCER RESEARCH (2009)
Identification of Allosteric PIF-Pocket Ligands for PDK1 using NMR-Based Fragment Screening and 1H-15N TROSY Experiments
Brian J. Stockman et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
3,5-Diphenylpent-2-enoic Acids as Allosteric Activators of the Protein Kinase PDK1: Structure-Activity Relationships and Thermodynamic Characterization of Binding as Paradigms for PIF-Binding Pocket-Targeting Compounds
Adriana Stroba et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1
Valerie Hindie et al.
NATURE CHEMICAL BIOLOGY (2009)
Development of High-Throughput TR-FRET and AlphaScreen (R) Assays for Identification of Potent Inhibitors of PDK1
Zangwei Xu et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
Small-Molecule Inhibitors of PDK1
Christian Peifer et al.
CHEMMEDCHEM (2008)
A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding
Marie A. Bogoyevitch et al.
DRUG DISCOVERY TODAY (2007)
AKT/PKB signaling: Navigating downstream
Brendan D. Manning et al.
CELL (2007)
Allosteric activation of the protein kinase PDK1 with low molecular weight compounds
Matthias Engel et al.
EMBO JOURNAL (2006)
Recent progress in development of non-ATP competitive small-molecule inhibitors of protein kinases
Alex Kiselyov et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2006)
Exploiting the PI3K/AKT pathway for cancer drug discovery
BT Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
In vivo role of the phosphate groove of PDK1 defined by knockin mutation
BJ Collins et al.
JOURNAL OF CELL SCIENCE (2005)
Hypomorphic mutation of PDK1 suppresses tumorigenesis in PTEN+/- mice
JR Bayascas et al.
CURRENT BIOLOGY (2005)
PDK1, the master regulator of AGC kinase signal transduction
A Mora et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2004)
Phosphoinositide-dependent protein kinase 1, a sensor of protein conformation
RM Biondi
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Virtual screening of chemical libraries
BK Shoichet
NATURE (2004)
In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation
BJ Collins et al.
EMBO JOURNAL (2003)
Mutants of protein kinase a that mimic the ATP-binding site of protein kinase B (AKT)
M Gassel et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions
RM Biondi et al.
BIOCHEMICAL JOURNAL (2003)
Binding of phosphatidylinositol 3,4,5-trisphosphate to the pleckstrin homology domain of protein kinase B induces a conformational change
CC Milburn et al.
BIOCHEMICAL JOURNAL (2003)
Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP
J Yang et al.
NATURE STRUCTURAL BIOLOGY (2002)
A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation
M Frödin et al.
EMBO JOURNAL (2002)
High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site
RM Biondi et al.
EMBO JOURNAL (2002)
Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation
J Yang et al.
MOLECULAR CELL (2002)
The conformational plasticity of protein kinases
M Huse et al.
CELL (2002)
The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB
RM Biondi et al.
EMBO JOURNAL (2001)
Structural basis for control by phosphorylation
LN Johnson et al.
CHEMICAL REVIEWS (2001)
Inhibition of PDK-1 activity causes a reduction in cell proliferation and survival
P Flynn et al.
CURRENT BIOLOGY (2000)
Cellular signaling: Pivoting around PDK-1
A Toker et al.
CELL (2000)
A 3-phosphoinositide-dependent protein kinase-1 (PDK1) docking site is required for the phosphorylation of protein kinase Cζ (PKCζ) and PKC-related kinase 2 by PDK1
A Balendran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1
M Frödin et al.
EMBO JOURNAL (2000)
Rho GTPase control of protein kinase C-related protein kinase activation by 3-phosphoinositide-dependent protein kinase
P Flynn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA
RM Biondi et al.
EMBO JOURNAL (2000)
Share Paper
